People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

Liver cancer remains a significant global health challenge and can develop silently in patients who are unaware they have underlying liver disease. To discuss this unmet need in cancer care, CURE sat ...

Liver cancer often develops in individuals with chronic liver disease, with hepatocellular carcinoma (HCC) and cholangiocarcinoma as the main types. HCC is commonly associated with hepatitis B or C, ...

Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among racial groups, a Cedars-Sinai Cancer study published in the journal Clinical ...

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

The research focused on the genetic faults that allow the disease to hijack a signalling system in the body.

A new report from the American Cancer Society shows cancer survival rates here in the U.S. have reached a new milestone.

LAOAG CITY, Ilocos Norte (PIA) — The Mariano Marcos Memorial Hospital and Medical Center (MMMHMC) is intensifying its ...

Immunotherapy-based combinations have rapidly replaced tyrosine kinase inhibitors as first-line treatment for advanced hepatocellular carcinoma, reshaping real-world practice over the past decade. In ...